FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/07/090636 [Registered on: 10/07/2025] Trial Registered Prospectively
Last Modified On: 10/07/2025
Post Graduate Thesis  Yes 
Type of Trial  Observational 
Type of Study   Cohort Study 
Study Design  Other 
Public Title of Study   Outcomes of elevated lactate levels in patients admitted to intensive care units 
Scientific Title of Study   An Observational Study on outcomes of hyperlactatemia on admission in critically ill patients.  
Trial Acronym  nil 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Pavithradevi S 
Designation  Msc Critical care technology 
Affiliation  Sri Ramachandra Institute of Higher Education and Reasearch 
Address  Sri Ramachandra Institute of Higher Education and Reasearch Department of Critical Care Medicine porur chennai

Chennai
TAMIL NADU
600116
India 
Phone  9940902112  
Fax    
Email  spavithradevipandi@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Baby sailaja 
Designation  Associate Professor 
Affiliation  Sri Ramachandra Institute of Higher Education and Reasearch 
Address  Sri Ramachandra Institute of Higher Education and Reasearch Department of Critical Care Medicine porur chennai

Chennai
TAMIL NADU
600116
India 
Phone  9600159482  
Fax    
Email  sailajaroop@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Renuka MK 
Designation  Professor and Head Of Department 
Affiliation  Sri Ramachandra Institute of Higher Education and Reasearch 
Address  Sri Ramachandra Institute of Higher Education and Reasearch Department of Critical Care Medicine porur chennai

Chennai
TAMIL NADU
600116
India 
Phone  8056126336  
Fax    
Email  renuka.mk@sriramachandra.edu.in  
 
Source of Monetary or Material Support  
SRI RAMACHANDRA INSTITUTE OF HIGHER EDUCATION AND RESEARCH Department of Critical Care Medicine Porur Chennai Tamil Nadu 600116 
 
Primary Sponsor  
Name  SRI RAMACHANDRA INSTITUTE OF HIGHER EDUCATION AND RESEARCH 
Address  Department of Critical Care Medicine Sri Ramachandra Institue Of Higher Education and Research Porur chennai 600116 
Type of Sponsor  Research institution and hospital 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
DR Renuka MK  Sri Ramachandra Institute of Higher Education and Reasearch  Department of critical care medicine Sri Ramachandra Medical College Trunk Rd Sri Ramachandra Nagar Porur Chennai Tamilnadu 600116.
Chennai
TAMIL NADU 
08056126336

renuka.mk@sriramachandra.edu.in 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
SriRamachandra Institution Of Higher Education And Research  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  , (1) ICD-10 Condition: R740||Nonspecific elevation of levels oftransaminase and lactic acid dehydrogenase [LDH],  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Nil  Nil 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  99.00 Year(s)
Gender  Both 
Details  patient with elevated lactate levels.
clinical conditions associated with tissue hypoxia and systemic disease.
all consecutive critically ill adult age above 19 years. 
 
ExclusionCriteria 
Details  neonates and paediatric patients.
incomplete records or missing data. 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
Development of multi organ dysfunction syndrome(MODS)
lactate clearance and its association with clinical deterioration
factors enchance lactate clearance at 24 hours and at 48 hours
abg
serum lactate
apache 2 score and sofa score 
8weeks 
 
Secondary Outcome  
Outcome  TimePoints 
length of ICU stay
need for organ suport(mechanical ventilation, vasopressors)
hospital mortality 
10 months 
 
Target Sample Size   Total Sample Size="100"
Sample Size from India="100" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   15/08/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="0"
Months="10"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  

Elevated lactate levels serve as a biomarker for tissue hypoperfusion and are indicative of severe illness, especially in critically ill patients. Monitoring the underlying causes of elevated lactate is crucial to prevent further clinical deterioration. Lactate measurements are typically obtained through arterial blood gas analysis at the time of ICU admission, as well as at 24 and 48 hours post-admission. High lactate levels at admission are strongly linked to increased ICU mortality. Patients with elevated lactate are more likely to develop multi-organ dysfunction and require intensive organ support, such as vasopressors and mechanical ventilation. Importantly, admission lactate levels are an independent predictor of poor outcomes, even when adjusted for established severity scoring systems like APACHE II and SOFA. Thus, early identification of elevated lactate can provide valuable prognostic information in the management of critically ill patients

 
Close